1. Eating Behavior in Functional Dyspepsia
   Younghee Choe et al, 2022, Journal of Neurogastroenterology and Motility CrossRef
2. Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users
   Daisuke Asaoka et al, 2019, Biomedical Reports CrossRef
3. Targeting the altered duodenal microenvironment in functional dyspepsia
   Matthias Ceulemans et al, 2023, Current Opinion in Pharmacology CrossRef
4. Recomendaciones de buena práctica clínica en el diagnóstico y tratamiento de la enfermedad por reflujo gastroesofágico. Revisión por expertos de la Asociación Mexicana de Gastroenterología
   M.A. Valdovinos-Diaz et al, 2024, Revista de Gastroenterología de México CrossRef
5. Management of GERD: Are Potassium-Competitive Acid Blockers Superior to Proton Pump Inhibitors?
   Yoshikazu Kinoshita et al, 2018, American Journal of Gastroenterology CrossRef
6. Pharmacological Treatment of Functional Dyspepsia: An Old Story Revisited or a New Story to Be Told? A Clinical Review
   Jéssica Chaves et al, 2023, GE - Portuguese Journal of Gastroenterology CrossRef
7. Treatment of Acid-related Diseases Using Potassium-competitive Acid Blockers
   Yoon Jin Choi, 2022, The Korean Journal of Gastroenterology CrossRef
8. Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study
   Yoshikazu Kinoshita et al, 2019, Clinical and Translational Gastroenterology CrossRef
9. Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases
   Xiaoxiao Yang et al, 2018, Digestive Diseases and Sciences CrossRef
10. Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease
    Ryota Niikura et al, 2018, Internal Medicine CrossRef
11. Drugs under development for the treatment of functional dyspepsia and related disorders
    Jan Tack et al, 2019, Expert Opinion on Investigational Drugs CrossRef
12. Management of functional dyspepsia in 2020: a clinical point of view
    Elena MOSSO et al, 2021, Minerva Gastroenterologica e Dietologica CrossRef
13. Clinical factors associated with stable treatment of chronic constipation in Japanese patients
    Kazuki Ishibashi et al, 2024, BMC Gastroenterology CrossRef
14. Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker
    Hideki Mori et al, 2019, Journal of Neurogastroenterology and Motility CrossRef
15. Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms
    Sean D. Delshad et al, 2020, Gastroenterology CrossRef
16. Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date
    Kentaro Sugano, 2018, Therapeutic Advances in Gastroenterology CrossRef
17. The Impact of Duodenal Mucosal Vulnerability in the Development of Epigastric Pain Syndrome in Functional Dyspepsia
    Tomoki Okata et al, 2022, International Journal of Molecular Sciences CrossRef
18. Current and emerging therapeutic options for the management of functional dyspepsia
    A. Vandenberghe et al, 2020, Expert Opinion on Pharmacotherapy CrossRef
19. History of gastroesophageal reflux disease in patients with suspected coronary artery disease
    Hiroki Teragawa et al, 2019, Heart and Vessels CrossRef
20. Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociación Mexicana de Gastroenterología
    M.A. Valdovinos Díaz et al, 2024, Revista de Gastroenterología de México (English Edition) CrossRef